A Study Of Development Strategy Of Nanjing A Pharmaceutical Companies

With the new medical reform to carry out, the pharmaceutical industry’scompetitiveness will also translate into policy application, system innovation, financingplatform, and R&D, production, business, marketing, brand and other aspects of thecomprehensive strength, how to improve the core competitiveness of enterprises, tobecome bigger and stronger every pharmaceutical enterprises are facing urgent problem.To solve the above problem, the scientific and reasonable development strategy is thenecessary theoretical foundation. In this paper, under the background of new medicalreform of pharmaceutical production enterprise development strategy research under thebackground of new medical reform to the medicine production enterprises especially inNanjing A pharmaceutical company to provide theoretical support for the development,under the background of new medical reform of pharmaceutical production enterprisesespecially in Nanjing A pharmaceutical company developing science decision-makingprovide reference.First of all, this article through to the Nanjing A pharmaceutical company’smacroeconomic environment, the pharmaceutical industry development trend andcompetition situation of the company to external environmental factors and internalresources and ability two respects, using the PEST analysis, SWOT analysis and fiveforces analysis, strategic analysis, a comprehensive, objective analysis, recognize thecompany the market environment and living conditions. Secondly, this paper appliesPotter’s competition theory, in the analysis of assessment of internal and external factorson the basis of a clear, Nanjing A pharmaceutical company’s strategic target and way, thedevelopment of competitive strategy. Finally, the article puts forward Nanjing Apharmaceutical company through giving full play to their advantages, shortcomings anddeficiencies, seize market opportunities, actively avoiding external risk, achieve the strategic goal of the company. And the adjustment of organizational structure, humanresources, financial cost control and enterprise culture and other aspects of theimplementation of the strategy of safeguard measures.